Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
$1.14B |
| 2 |
AbbVie
ABBV
|
$537M |
| 3 |
T-Mobile US
TMUS
|
$504M |
| 4 |
Baidu
BIDU
|
$474M |
| 5 |
Kroger
KR
|
$448M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$1.32B |
| 2 |
AGN
Allergan plc
AGN
|
$1.26B |
| 3 |
S
Sprint Corporation
S
|
$675M |
| 4 |
Nabors Industries
NBR
|
$638M |
| 5 |
Amgen
AMGN
|
$504M |
Sector Composition
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.11% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $2.56B | 2.21% | 43,497,131 -22,494,980 | -34% | -$1.32B |
|
2
Novo Nordisk
NVO
$251B
| $1.88B | 1.62% | 28,709,831 +849,605 | +3% | +$55.6M |
|
|
3
AbbVie
ABBV
$372B
| $1.87B | 1.61% | 19,021,869 +5,466,020 | +40% | +$537M |
|
|
4
Zoom
ZM
$24.4B
| $1.84B | 1.59% | 7,256,035 +4,478,495 | +161% | +$1.14B |
|
5
Chipotle Mexican Grill
CMG
$56.5B
| $1.7B | 1.47% | 1,614,342 -224,900 | -12% | -$237M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $1.68B | 1.45% | 5,781,332 -1,078,350 | -16% | -$313M |
|
7
VeriSign
VRSN
$25.5B
| $1.51B | 1.31% | 7,310,690 -794,600 | -10% | -$164M |
|
8
Atlassian
TEAM
$46.6B
| $1.23B | 1.06% | 6,835,013 +400,989 | +6% | +$72.3M |
|
9
Tesla
TSLA
$1.08T
| $1.2B | 1.03% | 1,106,906 +339,400 | +44% | +$366M |
|
|
10
Baidu
BIDU
$32.8B
| $1.16B | 1% | 9,663,857 +3,953,814 | +69% | +$474M |
|
11
Palo Alto Networks
PANW
$127B
| $1.15B | 0.99% | 4,990,252 -429,099 | -8% | -$98.6M |
|
12
Biogen
BIIB
$19.4B
| $1.05B | 0.9% | 3,905,922 -567,990 | -13% | -$152M |
|
13
Pinduoduo
PDD
$171B
| $957M | 0.83% | 11,150,680 +3,279,206 | +42% | +$281M |
|
14
Target
TGT
$43.6B
| $945M | 0.82% | 7,880,897 +871,738 | +12% | +$105M |
|
15
Walmart
WMT
$774B
| $929M | 0.8% | 7,757,614 -2,044,600 | -21% | -$245M |
|
16
Humana
HUM
$36.5B
| $902M | 0.78% | 2,327,242 -1,201,900 | -34% | -$466M |
|
17
Monster Beverage
MNST
$60.9B
| $895M | 0.77% | 12,907,590 -699,002 | -5% | -$48.5M |
|
|
18
Kroger
KR
$44.9B
| $887M | 0.77% | 26,212,088 +13,242,785 | +102% | +$448M |
|
19
GSK
GSK
$79.9B
| $838M | 0.72% | 20,551,254 -2,525,200 | -11% | -$103M |
|
20
Fortinet
FTNT
$60.4B
| $820M | 0.71% | 5,973,687 -90,701 | -1% | -$12.5M |
|
21
Newmont
NEM
$81.7B
| $794M | 0.69% | 12,856,785 +903,598 | +8% | +$55.8M |
|
22
Franco-Nevada
FNV
$36.3B
| $792M | 0.68% | 5,672,083 +767,265 | +16% | +$107M |
|
23
Novartis
NVS
$245B
| $724M | 0.63% | 8,294,608 -196,800 | -2% | -$17.2M |
|
|
B
24
Barrick Mining Corporation
B
$45.4B
| $722M | 0.62% | 26,806,209 +1,673,938 | +7% | +$45.1M |
|
25
eBay
EBAY
$41.4B
| $697M | 0.6% | 13,279,334 +789,463 | +6% | +$41.4M |
|